Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Nov 17, 2015 12:31 pm EST

OPKO Health to Present at the Jefferies Autumn 2015 Global Healthcare Conference

Nov 16, 2015 11:26 am EST

OPKO Licensee TESARO Announces the Launch of VARUBI(TM) (Rolapitant) in the United States

Nov 12, 2015 9:20 am EST

OPKO 4Kscore Test Receives Category I CPT Code Approval

Nov 9, 2015 4:13 pm EST

OPKO Announces Third Quarter Financial and Operating Results

Nov 6, 2015 11:24 am EST

OPKO Health Refinances Bio-Reference Laboratories Credit Facility

Nov 5, 2015 1:58 pm EST

OPKO to Announce Third Quarter Operating and Financial Results on November 9, 2015

Nov 5, 2015 8:30 am EST

Additional Phase 3 Data Supporting OPKO’s Rayaldee as a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at Kidney Week 2015

Oct 22, 2015 8:00 am EDT

OPKO Health Expands Portfolio of Tests for Inherited Forms of Cancer

Oct 21, 2015 11:30 pm EDT

OPKO Health’s GeneDx business Presenting at National Society of Genetic Counselors Annual Meeting

Oct 13, 2015 8:00 am EDT

Vanderbilt University School of Medicine and OPKO Health Collaborate on Genomics